MedReleaf and BioPharma Services Inc. announce Strategic Alliance

MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company") and BioPharma Services Inc. (BioPharma) today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf's clinic development team.

Aphria Forms Landmark Venture with South African Company Verve Group of Companies

Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements (the "Transaction") resulting in Aphria forming a joint venture, CannInvest Africa Ltd. ("CannInvest"), with South African company Verve Group of Companies ("VGC").

Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to Massachusetts

Liberty Health Sciences Inc. (CSE: LHS ( ) (OTCQX: LHSIF) ("Liberty" or the "Company") today announced the expansion of the Company's partnership with Colorado-based MM Technology Holdings, LLC ("Mary's") to be the exclusive provider of the award-winning line of Mary's Medicinals® cannabis products in Massachusetts.

Future Farm Agrees to Acquire 10% of Arizona Medical Marijuana Cultivation and Processing Management Company

Future Farm Technologies Inc. (the "Company" or "Future Farm") (CSE: FFT) (CSE: FFT.CN) (OTCQX: FFRMF) is pleased to announce that it has agreed to invest $500,000 for a 10% interest in a limited liability company (the "Arizona Operator"), providing turn-key services related to the management, administration and operation of a 70,000 square foot licensed medical marijuana cultivation and processing facility in the State of Arizona. The transaction is expected to close in the next 45 days.